The suppression of TXNIP and miR-200c improve beta-cell function in patients with Type 2 diabetes: A randomized, double-blind, placebo-controlled trial

The suppression of TXNIP and miR-200c improve beta-cell function in patients with Type 2 diabetes: A randomized, double-blind, placebo-controlled trial

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Functional Foods - Volume 48, September 2018, Pages 481-489

Neda Roshanravan, Reza Mahdavi, Mohammad Asghari Jafarabadi, Effat Alizadeh, Shahriar Alipour, Abed Ghavami, Naimeh Mesri Alamdari, Mehdi Hedayati, Meisam Barati, Behzad Mansoori, Alireza Ostadrahimi,